Digital health company Metronomic has acquired Iron Health, a tech-enabled women’s health provider that serves as an extension of OB/GYN practices. The acquisition, completed on December 30, 2024, aims to integrate Iron Health’s care delivery services with Metronomic’s Materno pregnancy management platform. Iron Health, founded in 2022, has raised $8.5M in funding since its inception and was backed by Redesign Health. The…
ScreenPoint Medical has announced the acquisition of Biomediq A/S, a research company specializing in quantitative imaging biomarkers. The acquisition follows a decade of collaboration between the companies on image-based risk assessment and aims to integrate breast cancer risk assessment capabilities into ScreenPoint’s Transpara Breast AI platform. Biomediq’s technology enables automatic computer-based analysis of 2D and 3D mammograms for future breast cancer risk…
When Roya Pakzad experienced severe side effects from birth control pills in 2018 – including mental health issues, weight gain, and chronic infections – she discovered firsthand the frustrating reality many women face in healthcare: either get dismissed by conventional doctors or pay thousands for functional medicine alternatives. This experience became the catalyst for Feminade, a startup aimed at making functional medicine…
Hologic has announced the completion of its acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health. The transaction, valued at approximately $350 million, brings Gynesonics’ Sonata System under Hologic’s portfolio of women’s health solutions. The Sonata System provides diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual…
Astorg, a pan-European private equity firm, has announced the completion of two simultaneous transactions: the take-private acquisition of Hamilton Thorne and the purchase of Cook Medical‘s Reproductive Health business (Cook Medical RH). Following these transactions, Hamilton Thorne has been delisted from the Toronto Stock Exchange. The combined entity will serve customers in over 115 countries, providing fertility clinics and IVF laboratories with…
Venture Life Group has announced the acquisition of Health & Her (H&H) for an upfront cash consideration of £7.5 million, with additional payments of up to £2.5 million tied to performance and retention milestones. The acquisition strengthens Venture Life’s position in the rapidly growing hormone health market. Founded in 2018 and headquartered in Cardiff (UK), H&H has established itself as a leading…
Caldera Medical has announced the acquisition of UVision360, developer of the LUMINELLE hysteroscopy and cystoscopy systems. The deal expands Caldera’s portfolio in minimally invasive solutions for diagnosing and treating conditions such as polyps, fibroids, and intrauterine pathology. “We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio,” said Bryon Merade, CEO of Caldera Medical. “This acquisition strengthens our commitment to…
AbbVie has announced the acquisition of Aliada Therapeutics for $1.4 billion in cash, strengthening its position in neuroscience drug development. The deal centers on Aliada’s novel blood-brain barrier (BBB)-crossing technology and its lead Alzheimer’s disease candidate, ALIA-1758, a development particularly significant given that women represent nearly two-thirds of Americans living with Alzheimer’s disease. Aliada’s proprietary MODEL platform enables high-precision central nervous system…
